REQUEST A DEMO
Total
USD $0.00
Search more companies

Anadolu Pharma Ecza Deposu Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Anadolu Pharma Ecza Deposu Limited Sirketi Profile Updated: November 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Anadolu Pharma Ecza Deposu Ltd. Sti. is based in Turkiye, with the head office in Konya. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on October 22, 2018. It currently has a total number of 75 (2025) employees. There was a net sales revenue increase of 59.88% reported in Anadolu Pharma Ecza Deposu Ltd. Sti.’s latest financial highlights for 2024. Its total assets grew by 67.27% over the same period. In 2024, Anadolu Pharma Ecza Deposu Ltd. Sti.’s net profit margin increased by 0.29%.

Headquarters
No:39-1 Fevzicakmak Mahallesi Hudai Caddesi Karatay
Konya; Central Anatolia; Postal Code: 42050

Contact Details: Purchase the Anadolu Pharma Ecza Deposu Ltd. Sti. report to view the information.

Website: http://www.anadoluecza.com

Basic Information
Total Employees:
Purchase the Anadolu Pharma Ecza Deposu Ltd. Sti. report to view the information.
Financial Auditors:
Purchase the Anadolu Pharma Ecza Deposu Ltd. Sti. report to view the information.
Incorporation Date:
October 22, 2018
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Anadolu Pharma Ecza Deposu Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
59.88%
Total operating revenue
59.88%
Operating profit (EBIT)
124.67%
Net Profit (Loss) for the Period
81.63%
Total Assets
67.27%
Total Equity
38.17%
Operating Profit Margin (ROS)
1.09%
Net Profit Margin
0.29%
Return on Equity (ROE)
3.28%
Debt/Equity
-0.79%
Quick Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?